Medicaid, private insurance, and the availability of smoking cessation interventions in substance use disorder treatment

Psychiatric Services

Volumn 66, Issue 11, 2015, Pages 1213-1220

  Knudsen, Hannah K ^a   Roman, Paul M ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE PATCH; VARENICLINE; NICOTINE GUM;

ARTICLE; COGNITIVE THERAPY; HEALTH CARE AVAILABILITY; HUMAN; MEDICAID; NICOTINE REPLACEMENT THERAPY; PRIVATE HEALTH INSURANCE; SMOKING CESSATION PROGRAM; SUBSTANCE ABUSE; SUSTAINED DRUG RELEASE; TOBACCO DEPENDENCE; UNITED STATES; COUNSELING; ECONOMICS; INSURANCE; MULTIVARIATE ANALYSIS; SMOKING CESSATION; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TOBACCO USE DISORDER;

BUPROPION; COUNSELING; HUMANS; INSURANCE CARRIERS; INSURANCE COVERAGE; LOGISTIC MODELS; MEDICAID; MULTIVARIATE ANALYSIS; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER; UNITED STATES; VARENICLINE;

EID: 84946606740     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/appi.ps.201400451     Document Type: Article

References (55)

1. McClure EA, Acquavita SP, Dunn KE, et al: Characterizing smoking, cessation services, and quit interest across outpatient substance abuse treatment modalities. Journal of Substance Abuse Treatment 46:194-201, 2014
2. Guydish J, Passalacqua E, Tajima B, et al: Smoking prevalence in addiction treatment: a review. Nicotine and Tobacco Research 13: 401-411, 2011
3. Teater B, Hammond GC: Exploring smoking prevalence, quit attempts, and readiness to quit cigarette use among women in substance abuse treatment. Social Work in Health Care 49:176-192, 2010
4. Cupertino AP, Hunt JJ, Gajewski BJ, et al: The index of tobacco treatment quality: development of a tool to assess evidence-based treatment in a national sample of drug treatment facilities. Substance Abuse Treatment, Prevention, and Policy 8:13, 2013
5. Muilenburg JL, Laschober TC, Eby LT: Organizational factors as predictors of tobacco cessation pharmacotherapy adoption in addiction treatment programs. Journal of Addiction Medicine 8: 59-65, 2014
6. Hurt RD, Offord KP, Croghan IT, et al: Mortality following in-patient addictions treatment. Role of tobacco use in a community-based cohort. JAMA 275:1097-1103, 1996
7. Hser YI, McCarthy WJ, Anglin MD: Tobacco use as a distal predictor of mortality among long-term narcotics addicts. Preventive Medicine 23:61-69, 1994
8. Tsoh JY, Chi FW, Mertens JR, et al: Stopping smoking during first year of substance use treatment predicted 9-year alcohol and drug treatment outcomes. Drug and Alcohol Dependence 114:110-118, 2011
9. Prochaska JJ, Delucchi K, Hall SM: A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. Journal of Consulting and Clinical Psychology 72:1144-1156, 2004
10. Hall SM, Prochaska JJ: Treatment of smokers with co-occurring disorders: emphasis on integration in mental health and addiction treatment settings. Annual Review of Clinical Psychology 5: 409-431, 2009
11. Schroeder SA, Morris CD: Confronting a neglected epidemic: tobacco cessation for persons with mental illnesses and substance abuse problems. Annual Review of Public Health 31:297-314, 2010
12. Richter KP, Arnsten JH: A rationale and model for addressing tobacco dependence in substance abuse treatment. Substance Abuse Treatment, Prevention, and Policy 1:23, 2006
13. Baca CT, Yahne CE: Smoking cessation during substance abuse treatment: what you need to know. Journal of Substance Abuse Treatment 36:205-219, 2009
14. Fiore MC, Jaen CR, Baker TB, et al: Treating Tobacco Use and Dependence: 2008 Update. Rockville, Md, US Department of Health and Human Services, Public Health Service, 2008
15. Friedmann PD, Jiang L, Richter KP: Cigarette smoking cessation services in outpatient substance abuse treatment programs in the United States. Journal of Substance Abuse Treatment 34:165-172, 2008
16. Knudsen HK, Muilenburg J, Eby LT: Sustainment of smoking cessation programs in substance use disorder treatment organizations. Nicotine and Tobacco Research 15:1060-1068, 2013
17. Knudsen HK, Studts JL: The implementation of tobacco-related brief interventions in substance abuse treatment: a national study of counselors. Journal of Substance Abuse Treatment 38:212-219, 2010
18. Knudsen HK, Studts CR, Studts JL: The implementation of smoking cessation counseling in substance abuse treatment. Journal of Behavioral Health Services and Research 39:28-41, 2012
19. Hunt JJ, Cupertino AP, Garrett S, et al: How is tobacco treatment provided during drug treatment? Journal of Substance Abuse Treatment 42:4-15, 2012
20. Rothrauff TC, Eby LT: Substance abuse counselors' implementation of tobacco cessation guidelines. Journal of Psychoactive Drugs 43:6-13, 2011
21. Knudsen HK, Studts JL: Availability of nicotine replacement therapy in substance use disorder treatment: longitudinal patterns of adoption, sustainability, and discontinuation. Drug and Alcohol Dependence 118:244-250, 2011
22. Rothrauff TC, Eby LT: Counselors' knowledge of the adoption of tobacco cessation medications in substance abuse treatment programs. American Journal on Addictions 20:56-62, 2011
23. Tobacco Use in Adults and Pregnant Women: Counseling and Interventions, April 2009. Rockville, Md, US Preventive Services Task Force, 2009. Available at www.uspreventiveservicestaskforce. org/Page/Document/ClinicalSummaryFinal/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions. Accessed Feb 2, 2015
24. Muilenburg JL, Laschober TC, Eby LT: Climate for innovation, 12-step orientation, and tobacco cessation treatment. Journal of Substance Abuse Treatment 46:447-455, 2014
25. Knudsen HK, Studts JL, Boyd S, et al: Structural and cultural barriers to the adoption of smoking cessation services in addiction treatment organizations. Journal of Addictive Diseases 29: 294-305, 2010
26. Hunt JJ, Gajewski BJ, Jiang Y, et al: Capacity of US drug treatment facilities to provide evidence-based tobacco treatment. American Journal of Public Health 103:1799-1801, 2013
27. Eby LT, Laschober TC, Muilenburg JL: Sustained, new, never, and discontinued tobacco cessation services adopters. Journal of Substance Abuse Treatment 49:8-14, 2015
28. Guydish J, Ziedonis D, Tajima B, et al: Addressing Tobacco Through Organizational Change (ATTOC) in residential addiction treatment settings. Drug and Alcohol Dependence 121:30-37, 2012
29. Pfeffer J: A resource dependence perspective on intercorporate relations; in Intercorporate Relations: The Structural Analysis of Business. Edited by Mizruchi MS, Schwartz M. Cambridge, England, Cambridge University Press, 1987
30. Pfeffer J: New Directions for Organization Theory: Problems and Prospects. New York, Oxford University Press, 1997
31. Fennell ML, Warnecke RB: The Diffusion of Medical Innovations: An Applied Network Analysis. New York, Plenum, 1988
32. Stewart MT, Horgan CH: Health services and financing of treatment. Alcohol Research & Health 33:389-394, 2011
33. Rieckmann TR, Kovas AE, Fussell HE, et al: Implementation of evidence-based practices for treatment of alcohol and drug disorders: the role of the state authority. Journal of Behavioral Health Services and Research 36:407-419, 2009
34. Terry-McElrath YM, Chriqui JF, McBride DC: Factors related to Medicaid payment acceptance at outpatient substance abuse treatment programs. Health Services Research 46:632-653, 2011
35. Knudsen HK, Roman PM: Financial factors and the implementation of medications for treating opioid use disorders. Journal of Addiction Medicine 6:280-286, 2012
36. Knudsen HK, Roman PM: The transition to medication adoption in publicly funded substance use disorder treatment programs: organizational structure, culture, and resources. Journal of Studies on Alcohol and Drugs 75:476-485, 2014
37. Abraham AJ, Knudsen HK, Rieckmann T, et al: Disparities in access to physicians and medications for the treatment of substance use disorders between publicly and privately funded treatment programs in the United States. Journal of Studies on Alcohol and Drugs 74:258-265, 2013
38. Roman PM, Johnson JA: Adoption and implementation of new technologies in substance abuse treatment. Journal of Substance Abuse Treatment 22:211-218, 2002
39. Sommers BD, Buchmueller T, Decker SL, et al: The Affordable Care Act has led to significant gains in health insurance and access to care for young adults. Health Affairs 32:165-174, 2013
40. A Closer Look at the Impact of State Decisions Not to Expand Medicaid on Coverage for Uninsured Adults. Menlo Park, Calif, Kaiser Family Foundation, 2014. Available at kaiserfamilyfoundation. files.wordpress.com/2014/04/8585-a-closer-look-at-the-impact-of-state-decisions-not-to-expand-medicaid.pdf
41. Buck JA: The looming expansion and transformation of public substance abuse treatment under the Affordable Care Act. Health Affairs 30:1402-1410, 2011
42. Health Reform Implementation Timeline. Menlo Park, Calif, Kaiser Family Foundation, 2014. Available at kff.org/interactive/implementation-timeline. Accessed on May 1, 2014
43. Claxton G, Levitt L, Brodie M, et al: Measuring Changes in Insurance Coverage Under the Affordable Care Act. Menlo Park, Calif, Kaiser Family Foundation, 2014 Available at kaiserfamilyfoundation. files.wordpress.com/2014/04/8586-measuring-changes-in-insurance-coverage-under-the-affordable-care-act3.pdf. Accessed May 1, 2014
44. Knudsen HK, Roman PM: Dissemination, adoption, and implementation of acamprosate for treating alcohol use disorders. Journal of Studies on Alcohol and Drugs 75:467-475, 2014
45. Aarons GA, Sommerfeld DH, Walrath-Greene CM: Evidence-based practice implementation: the impact of public versus private sector organization type on organizational support, provider attitudes, and adoption of evidence-based practice. Implementation Science 4:83, 2009
46. Census Regions and Divisions of the United States. Washington, DC, US Census Bureau, 2014. Available at http://www.census.gov/geo/maps-data/maps/pdfs/reference/us-regdiv.pdf. Accessed Jan 21, 2015
47. Allison PD: Missing data; in The SAGE Handbook of Quantitative Methods in Psychology. Edited by Millsap RE, Maydeu-Olivares A. Thousand Oaks, Calif, Sage, 2009
48. Menard SW: Applied Logistic Regression Analysis. Thousand Oaks, Calif, Sage, 1995
49. Long JS, Freese J: Regression Models for Categorical Dependent Variables Using Stata, 2nd ed. College Station, Tex, StataCorp, 2006
50. Garfield RL, Lave JR, Donohue JM: Health reform and the scope of benefits for mental health and substance use disorder services. Psychiatric Services 61:1081-1086, 2010
51. Singleterry J, Jump Z, Lancet E, et al: State Medicaid coverage for tobacco cessation treatments and barriers to coverage-United States, 2008-2014. Morbidity and Mortality Weekly Report 63: 264-269, 2014
52. Kofman M, Dunton K, Senkewicz MB: Implementation of Tobacco Cessation Coverage Under the Affordable Care Act: Understanding How Private Health Insurance Policies Cover Tobacco Cessation Treatments. Washington, DC, Georgetown University Health Policy Institute, 2012. Available at www.tobaccofreekids.org/pressoffice/2012/georgetown/coveragereport.pdf. Accessed Feb 2, 2015
53. Helping Smokers Quit: Tobacco Cessation Coverage 2014. Washington, DC, American Lung Association, 2014. Available at www.lung.org/assets/documents/publications/smoking-cessation/helping-smokers-quit-2014.pdf. Accessed Feb 2, 2015
54. FAQs About Affordable Care Act Implementation (Part XI). Washington, DC, United States Department of Labor, 2014. Available at www.dol.gov/ebsa/faqs/faq-aca19.html. Accessed Feb 2, 2015
55. Knudsen HK, Boyd SE, Studts JL: Substance abuse treatment counselors and tobacco use: a comparison of comprehensive and indoor-only workplace smoking bans. Nicotine and Tobacco Research 12:1151-1155, 2010